PATENT CLAIM ANALYSIS

Application Number: 16230634
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "345000"]

Abstract:
Provided is a heterocyclic compound having a superior RBP4-lowering action and useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4. A compound represented by the formula (I): wherein each symbol is as defined in the Description, or a salt thereof has a superior RBP4-lowering action, and is useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4.

Claim (Index 28):
The method of  claim 24 , wherein the compound is ((1-(3,5-bis(Trifluoromethyl)phenyl)-1H-pyrazol-3-yl)oxy)acetic acid or a salt thereof.

Metadata:
- Claim Count in Document: 113.0
- Percentile: 98.0
- Lexical Diversity: 2.06522
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15517227', '12994329', '13264510', '10594996', '15518782']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7753775319176275
- 35 USC 102 Novelty (BERT): 0.5968092052174011
- Combined Prediction Score: 0.7575206992476049
- Mean Citation Score: 365.639476
- Max Citation Score: 554.4425
- Similarity Product: 409.68050768941634

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test